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Background: Array-based comparative genomic hybridization has been assumed to be the first genetic test offered to
detect genomic imbalances in patients with unexplained intellectual disability with or without dysmorphisms, multiple
congenital anomalies, learning difficulties and autism spectrum disorders.
Our study contributes to the genotype/phenotype correlation with the delineation of laboratory criteria which help to
classify the different copy number variants (CNVs) detected. We clustered our findings into five classes ranging from an
imbalance detected in a microdeletion/duplication syndrome region (class I) to imbalances that had previously been
reported in normal subjects in the Database of Genomic Variants (DGV) and thus considered common variants (class IV).
Results: All the analyzed 1000 patients had at least one CNV independently of its clinical significance. Most of them, as
expected, were alterations already reported in the DGV for normal individuals (class IV) or without known coding genes
(class III-B). In approximately 14 % of the patients an imbalance involving known coding genes, but with partially
overlapping or low frequency of CNVs described in the DGV was identified (class IIIA). In 10.4 % of the patients a
pathogenic CNV that explained the phenotype was identified consisting of: 40 class I imbalances, 44 class II de novo
imbalances and 21 class II X-chromosome imbalances in male patients. In 20 % of the patients a familial pathogenic or
potentially pathogenic CNV, consisting of inherited class II imbalances, was identified that implied a family evaluation by
the clinical geneticists.
Conclusions: As this interpretation can be sometimes difficult, particularly if it is not possible to study the parents, using
the proposed classification we were able to prioritize the multiple imbalances that are identified in each patient without
immediately having to classify them as pathogenic or benign.
Keywords: Array comparative genomic hybridization (array-CGH), Copy number variation (CNV) classification, Intellectual
disability, Multiple congenital anomalies, Learning difficulties, Autism spectrum disordersBackground
Microarray-based comparative genomic hybridization
(array-CGH), also called chromosomal microarray or
molecular karyotyping, allows the possibility to screen
the whole genome at once and with high resolution. It is* Correspondence: citogenetica@fmed.uc.pt
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(http://creativecommons.org/publicdomain/zecurrently assumed that array-CGH should be the first
genetic test offered to detect genomic imbalances in pa-
tients with intellectual disability (ID) with or without
dysmorphisms, multiple congenital anomalies (MCA),
learning difficulties and autism spectrum disorders
(ASD) [1, 2]. As array-CGH allows the detection of im-
balances below the 5–10 Mb resolution level of conven-
tional cytogenetics, the average diagnostic yield can be
up to 10 % higher [3–7]. It also allows the detection of a
large number of Copy Number Variants (CNVs) in these
patients as well as in healthy individuals, which poses a
great challenge in the interpretation of the results [8]. Ine is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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the use of array-CGH in large cohorts of patients
with ID, ASD and MCA has led to the identification
of novel microdeletion and microduplication syn-
dromes [9, 10].
In this study we report the frequency of imbalances,
their inheritance and conclusions of a cohort of 1000 pa-
tients with ID, ASD, MCA and learning disabilities stud-
ied by array-CGH. We propose a classification of CNVs
into five different classes as a way to prioritize the mul-
tiple imbalances detected in each patient, helping not
only the organization and interpretation of the results,
but also in those cases where parents were unwillingly
to be tested or were unavailable, the elaboration of a
more comprehensive report.Results
A cohort of a 1000 patients with ID, MCA and/or ASD
was studied by array CGH using an oligonucleotide plat-
form. After array analysis, detected CNVs were classified
into 5 different classes (Table 1): class I - deletions or du-
plications in a region associated with a microdeletion or a
microduplication syndrome; class II - deletions or duplica-
tions in a region not reported in the Database of Genomic
Variants (DGV) and involving known coding genes; class
IIIA- deletions or duplications reported in low frequency
in DGV or that do not totally overlapped with the ones re-
ported, involving known coding regions; class IIIB - dele-
tions or duplications reported in low frequency in DGV or
that do not totally overlapped with the ones reported,
without involving known coding genes; class IV - deletionsTable 1 Class definition of CNVs depending on its clinical significanor duplications reported in normal subjects in DGV or
that are considered common variants.
When a class I or class II CNV was found, the study of
the parents was requested in order to ascertain its origin
and delineate the strategy for family management and fu-
ture prenatal diagnosis. For cases where a IIIA CNV was
identified, decision whether or not to pursue with parental
evaluation was left to the clinicians. For class IIIB and
class IV CNVs no study of parents was needed, and a nor-
mal array-CGH result was issued. Since class IIIB CNVs
at present do not have genes reported, no causality was at-
tributed, but the information was included in a summary
table in the report, to allow a future revision, if genes or
regulatory regions are later described.
There were cases where the origin of the imbalances
was not possible to determine, either because of unwill-
ingness of both parents to be evaluated, in situations of
adoption or in monoparental cases in which the available
progenitor was not a carrier of the proband’s CNVs.
In our cohort we identified at least one class IV
CNV in each patient. As they are considered benign
copy number variations present in normal individuals,
like the results by Choucair and collaborators [11],
class IV imbalances were disregarded for the fre-
quency evaluation. In this study group, 489 patients
only had class IV imbalances. Excluding class IV
CNVs, we identified a total of 843 CNVs in the
remaining 611 cases: 40 as class I (4.8 %), 452 as
class II (53.6 %), 166 as class IIIA (19.7 %) and 185
as class IIIB (21.9 %) (Fig. 1).
The distribution of all the imbalances from the differ-
ent classes according to genomic size was evaluatedce
Fig. 1 Distribution of the 843 CNVs identified in 611 of the 1000
cases by classes I to IIIA: 40 imbalances belong to class I (4.8 %), 452
to class II (53.6 %), 166 to class IIIA (19.7 %) and 185 to class
IIIB (21.9 %)
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the genomic size of the imbalance increases, the prob-
ability to find imbalances from the four classes reduces.
Above 3 Mb in size we only found imbalances belonging
to class I and II. There is an association with statistical
significance (χ2(1) = 40.591; p < 0.001) between class I
and II and sizes above 3 Mb, and between class IIIA and
IIIB and sizes below 3 Mb.Fig. 2 Distribution of all the imbalances according to the genomic size. As th
from the four classes reduces. Above 3 Mb in size only imbalances belonging
as they are considered benign copy number variations. There is an association
and II and sizes above 3 Mb and between classes IIIA and IIIB and sizes belowClass I imbalances (Table 2) were present in 40 pa-
tients: twenty-two deletions and sixteen duplications, a
triple X and a Klinefelter syndrome which were con-
firmed without other clinical significant imbalances
present. Fifteen imbalances were de novo, two maternal,
four paternal and in nineteen cases the inheritance was
not possible to determine. Table 3 contains the list of all
the syndromes identified and the number of cases within
each one. Of the 40 imbalances, 42.5 % had between 1–
3 Mb in size, eleven cases (27.5 %) had a genomic size
between 1-2 Mb and six (15 %) an imbalance with 2-
3 Mb, with the remaining distributed by different gen-
omic ranges (Fig. 2). The smallest class I imbalance de-
tected corresponds to a 184 kb deletion in 8q22.2
involving Cohen syndrome gene, COH1, and the largest,
disregarding the triple X and Klinefelter cases, corre-
sponds to a 30 Mb deletion at the short arm of chromo-
some 5, involving the Cri du Chat region. In 38 % of the
cases the imbalances were de novo and in 48 % it was
not possible to ascertain the family inheritance. From
the available data, it was shown that chromosome 3q29
deletion and the 17q12 duplication were similarly ob-
served in the mothers, while the chromosomes 3q29 du-
plication syndrome, 16p11.2 deletion syndrome and
22q11.2 duplication and deletion syndromes were ob-
served similarly in the male progenitors.
We detected 452 class II imbalances present in 340
cases, since some patients had multiple imbalances classi-
fied in this class. Of the 452 alterations, 191 were deletions
(42.25 %), 255 duplications (56.42 %), two were X-
chromosome triplications (0.44 %) and the remaining four
were tetrasomies (0.89 %) (Table 4). Considering thee genomic size of the imbalance increases, the number of imbalances
to classes I and II are observed. Class IV imbalances are not represented
with statistical significance (χ2(1) = 40.591; p < 0.001) between classes I
3 Mb – dashed line
Table 2 Class I imbalances distributed according to the type of
imbalance and inheritance
Imbalance Deletion Duplication Klinefelter Triple
XInheritance
De novo 8 5 1 1 15
Maternal 1 1 0 0 2
Paternal 2 2 0 0 4
Unknown 11 8 0 0 19
22 16 1 1 40
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tween 1.9 kb, that corresponds to the size of the smallest
imbalance detected (a deletion), and 500 kb. 15 % of the
cases had an imbalance between 1–5 Mb, with the
remaining distributed by different genomic ranges, as ob-
served in Fig. 2.
Analyzing class II imbalances in respect to inheritance
pattern, there was a clear difference considering the dis-
tribution of inherited vs de novo imbalances: 82 % of the
inherited CNVs had a genomic size ranging from
1.985 kb to 600 kb, against 28 % of the de novo, while
51 % of the de novo imbalances had a genomic sizeTable 3 List of all the syndromes identified (class I imbalances) and
Syndrome Chromo
Chromosome 1q21.1 deletion syndrome 1q21.1
Chromosome 1q21.1 duplication syndrome 1q21.1
Chromosome 3q29 deletion syndrome 3q29
Chromosome 3q29 duplication syndrome 3q29
Wolf-Hirschhorn syndrome 4p16.3
Cri du Chat syndrome 5p
Williams-Beuren region duplication syndrome 7q11.23
Cohen syndrome 8q22.2
Chromosome 9p deletion syndrome 9p
Kleefstra syndrome 9q34.3
Chromosome15q11q13 duplication syndrome 15q11q1
Chromosome 15q13.3 deletion syndrome 15q13.3
Chromosome 16p11.2 deletion syndrome 16p11.2
Chromosome 16p11.2 duplication syndrome 16p11.2
Smith –Magenis syndrome 17p11.2
Potocki-Lupski syndrome 17p11.2
Chromosome 17q12 duplication syndrome 17q11.2
Chromosome 19q13.11 deletion syndrome 19q13.11
Chromosome 22q11.2 deletion syndrome, distal 22q11.2
Chromosome 22q11.2 duplication syndrome 22q11.2
Triple X X
Klinefelter X
mat maternal origin, pat paternal origin, dn de novo, na inheritance not availableranging from 1 to 5 Mb. The higher the genomic size of
the imbalance, the lower the probability of being inher-
ited (Fig. 3). Our data show a significant association
(χ2(1) = 44.456; p < 0.001) between de novo imbalances
and sizes above 500 kb and between inherited imbal-
ances and sizes below 500 kb.
One hundred and sixty-six class IIIA imbalances were
identified in 137 different patients: sixty deletions
(36.15 %), 103 duplications (62.05 %) and three amplifi-
cations (1.8 %). To date, only one patient whose parents
were studied revealed to have a de novo class IIIA imbal-
ance. In the others there was a similar proportion of ma-
ternal and paternal inheritance (Table 5). The maximum
genomic size of imbalances in this class was 2.5 Mb,
with 84 % of the imbalances ranging from 1.9 kb and
400 kb (Fig. 2).
We identified 185 class IIIB imbalances, fifty-six de-
letions (30.3 %), thirty duplications (16.2 %) and
ninety-nine variations (53.5 %), ranging from 284 bp
to 1.4 Mb, with 84 % of them having between
284 bp-200 kb.
In the studied cohort of patients, we concluded that
the great majority, 76 % of all the inherited CNVs identi-
fied were smaller than 500 kb, as Fig. 4 illustrates.the number of cases
some OMIM ID Number of cases
612474 3 na
612475 1 na
609425 1 mat
611936 2 (1pat, 1na)
194190 1 dn
123450 1 na
609757 2 (1dn, 1na)
216550 1 na
158170 1 dn
610253 1 na
3 608636 1 na
612001 1 na
611913 5 (1pat, 2dn, 2na)
614671 3 (1dn, 2na)
182290 1 na
610883 2 dn
614526 2 (1mat,1na)
613026 1 dn
611867 5 (1pat, 3dn, 1na)
608363 3 (1pat, 1dn, 1na)
1dn
1dn
Table 4 Class II imbalances distributed according to the type of imbalance and inheritance
Imbalance Deletion Duplication Triplication Tetrasomy
Inheritance
De novo 30 13 0 1 44
Maternal 38 74 0 2 114
Paternal 38 48 0 0 86
Maternal and paternal 1 0 0 1 2
Unknown 84 120 2 0 206
191 255 2 4 452
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Array-CGH has proven to be an important tool not
only in the detection of submicroscopic chromo-
somal imbalances and delineation of structural im-
balances but also in the establishment of genotype/
phenotype correlation. All of the 1000 cases studied
in this cohort presented ID with or without dys-
morphisms, learning difficulties, MCA or ASD. All
of them had imbalances detected by array-CGH.
Overall, there were 843 imbalances (class I-III) in
611 of the 1000 cases (Fig. 1). Imbalances classified
as class IV are not discussed as they correspond to
benign CNVs. In order to define the relevance of the
identified imbalances and their correlation with the
identified phenotypes we classified them into five
classes:Fig. 3 Class II de novo and inherited imbalances. In 82 % of the inherited C
28 % of the de novo, while 51 % of the de novo imbalances had a genom
imbalance, the lower the probability of being inherited. Our data show a s
imbalances and sizes above 500 kb and between inherited imbalances andClass I - Deletion or duplication in a region associated
with a microdeletion or a microduplication syndrome
Of the 1000 patients, forty (4 %) fitted into this cat-
egory with more deletions compared to duplications.
In a study by Shoukier and collaborators, in 342 pa-
tients, 42 (12 %) had an imbalance that corresponded
to a known microdeletion or microduplication syn-
drome, with a higher proportion of deletions to dupli-
cations (33 vs 9) [12]. The most common findings in
our cohort were imbalances involving 16p11.2 and
22q11.2 microdeletion/duplication syndromes region,
interestingly the same result as recently reported by
Ahn et al, 2013 [13]. In the cases where pattern of
inheritance was studied, as expected, most of them
were de novo. One of these cases had a de novo
19q13.11q13.12 deletion that provides evidence forNVs had a genomic size ranging from 1.985 kb to 600 kb, against
ic size ranging from 1 to 5 Mb. The higher the genomic size of the
ignificant association (χ2(1) = 44.456; p < 0.001) between de novo
sizes below 500 kb – dashed line
Table 5 Class IIIA imbalances distributed according to the type
of imbalance and inheritance
Imbalance Deletion Duplication Amplification
Inheritance
De novo 0 1 0 1
Maternal 10 9 0 19
Paternal 10 6 0 16
Unknown 83 44 3 130
103 60 3 166
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cutis aplasia [14].
Of the six inherited imbalances, three were dele-
tions in chromosomes 3q29, 16p11.2 and 22q11.2,
and three were duplications, in 3q29, 17q12 and
22q11.2. The 3q29 deletion and the 17q12 duplication
were maternally inherited, while the 3q29 and
22q11.2 duplications and the 16p11.2 and 22q11.2 de-
letions were paternal in origin. In the results by
Shoukier and collaborators, half of the 42 imbalances
were de novo, 9 were maternally inherited, with 4 im-
balances on the X-chromosome, and in 12 inheritance
was unknown [12].
Concerning inherited CNVs, the difficulties in inter-
pretation are due to: 1) incomplete penetrance; 2)Fig. 4 Inherited CNVs distribution according to genomic size. 76 % of all thphenotypic variability; and 3) lack of clinical evaluation
of the carrier progenitor. The chromosome 16p11.2 de-
letion was inherited from a healthy father, which is
commonly reported in the literature and in agreement
with the variable clinical outcome associated with this
imbalance that can include a normal phenotype [12,
15]. Concerning chromosome 22q11.2 imbalances, the
father with the 22q11.2 duplication is healthy, having
however only completed the basic scholarship but is
currently not able to read or write and his ID is simi-
lar to his daughter. The chromosome 22q11.2 dele-
tion is inherited from the paternal grandmother, and
the proband is the only one with phenotypic features.
These cases clearly show the inter and intra-familial
phenotypic variability associated with this imbalance
[16]. The 3q29 deletion was inherited from the
mother without ID but that had learning difficulties,
and actually presents speech difficulties and psychi-
atric disease. The 3q29 duplication and the 17q12 du-
plication were inherited from healthy progenitors that
have only completed basic scholarship.
The inherited cases posed a delicate problem, in terms
of future pregnancies, in healthy parents that had an ap-
parently normal phenotype, even though many of them
had only completed basic schooling.
Class I imbalances are considered pathogenic and mo-
lecular/conventional cytogenetics-FISH study of thee inherited CNVs identified were smaller than 500 kb
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anced rearrangement (Table 1).
Class II - Deletion or duplication not reported in the DGV
and involving known coding genes
In the studied cohort, 34 % of the patients demonstrated
452 class II imbalances (Fig. 1). This high percentage is
most probably due to the fact that the first 250 cases of
this cohort of patients were highly selected as they had a
strong clinical phenotype, normal karyotype and most
had a normal subtelomeric analysis by fluorescence in
situ hybridization (FISH) or multiplex ligation-
dependent probe amplification (MLPA). Patient selection
is one of the factors that most influences the diagnostic
yield, as stated by Shoukier and collaborators, whose co-
hort of patients had already performed conventional
cytogenetics and subtelomere screening before array-
CGH, similar to our first 250 patients [12].
Almost 50 % of the identified class II imbalances were
inherited, making the genotype/phenotype correlation
difficult to establish as most of the carrier progenitors
had apparently normal phenotypes, although they have
not been through a thorough clinical evaluation. As pre-
viously mentioned, larger inherited imbalances also had
a phenotypic manifestation in the carrier progenitor.
Smaller inherited imbalances can either not be the cause
of the proband’s phenotype or can have incomplete
penetrance in the carrier progenitor. There are some ex-
ceptions, as for example the 12.5 Mb inherited imbal-
ance that corresponds to an X-chromosome duplication
in a boy, inherited from his healthy mother, which illus-
trates how X-chromosome inactivation in females can
mask large imbalances. In the range of 8–9 Mb we iden-
tified a chromosome 4 maternal duplication in a girl
with attention-deficit hyperactivity disorder whose
mother presented learning difficulties at school [17]. In
the 6–7 Mb range two imbalances were identified: in
18p11.32p11.31 with 6.9 Mb duplication and in
8p21.3p21.1 with 6.2 Mb duplication both inherited
from affected fathers, one with ID and the other with
learning difficulties, as he only completed basic school.
Class II imbalances have a spectrum that ranges from
pathogenic, potentially pathogenic to uncertain signifi-
cance but likely pathogenic (Table 1). In this type of im-
balance, the study of parents is recommended and helps
the prioritization of CNVs – if de novo, CNV is most
likely pathogenic.
Class IIIA - Deletion or duplication reported in low
frequency in the DGV or that do not totally overlap with
the ones reported, involving known coding genes
Imbalances classified in this class corresponded to 20 %
of all the identified CNVs (Fig. 1). These CNVs can be
population CNVs with low representation in the publicdatabases. This class includes imbalances of uncertain
significance tending to be probably benign. In only one
patient inheritance was determined to be de novo, and in
this patient the imbalance might be considered of uncer-
tain significance but likely pathogenic.
Class IIIA imbalances have uncertain significance, ran-
ging from likely pathogenic to likely benign (Table 1). In
this type of CNVs, the study of parents is optional and
the management of the origin and its impact has to be
evaluated in the clinical context.
Class IIIB - Deletion or duplication reported in low
frequency in the DGV or that do not totally overlap with
the ones reported, without known coding genes
In this cohort of patients, 22 % of the imbalances were
classified as IIIB. Accordingly to the available data, as
they do not include genes, these imbalances were not
considered relevant for the phenotype. Nevertheless,
they were included in a table attached to the report sent
to the clinician, allowing these cases to be revisited and
reclassified in the light of future knowledge.
Class IIIB imbalances have uncertain significance, but
being likely benign (Table 1). The study of parents is not
recommended.
Conclusion
Array-CGH has revolutionized post natal cytogenetics
diagnostic, increasing the detection rate and replacing
conventional cytogenetics [1]. However, karyotyping can-
not be completely abandoned and, in certain cases, both
techniques should be performed in order to understand
the biological mechanism involved in the origin of an
imbalance and contribute, not only to identify the car-
riers, but also to do a correct evaluation of the recur-
rence risk in these families. The importance of the
proposed CNVs prioritization arises, specially, when a
preliminary report is done requesting parental studies. It
was important for the clinical management of the family
to have an indication of the relationship between the
genotype and the phenotype. Classifying CNVs in differ-
ent classes allowed us to establish the continuum patho-
genic–benign and their final impact on the phenotype,
after determining their origin. In classes I and II, paren-
tal blood samples were always requested to determine
the origin of the imbalance either by array-CGH, MLPA,
FISH or karyotype. Prenatal diagnosis was recommended
in subsequent gestations to progenitors from classes I
and II probands. In class IIIA imbalances it was left to
clinicians’ criteria, after the genetic counseling, the ne-
cessity to perform subsequent laboratory and familial
studies. For classes IIIB and IV no parental blood sam-
ples were requested by the laboratory, but these results
were sent to the clinician in a table attached to the re-
port for future management.
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particularly when a report had to be issued requesting
parents study.
Methods
Patients
A cohort of 1000 unrelated patient samples was analyzed
by oligoarray-CGH in our Cytogenetics and Genomics
laboratory over a period of 3 years. The samples were
provided by clinical geneticists and pediatricians from 3
national hospitals, as part of a common undertaking to
determine the etiology of ID with or without dysmorph-
isms, learning difficulties, MCA and ASD. The levels of
ID of our patients ranged from mild to moderate or se-
vere as determined by the gold standard scales and the
ASD patients were evaluated by ADI-R and ADOS. The
study was approved by the Hospitals Ethics Committee.
Various techniques were used to confirm and
characterize the imbalances identified by oligoarray-
CGH, such as, high resolution conventional cytogenetics,
FISH or MLPA, depending on the type and dimension
of the imbalance and availability of FISH and MLPA
probes in the laboratory. In order to determine the ori-
gin of the imbalances, parental blood samples were re-
quested and, additionally to the previous mentioned
techniques, array-CGH was also used in particular cases.
In 325 patients conventional cytogenetics had been
previously performed. Fourteen patients with an abnor-
mal karyotype were analyzed by array-CGH. Of those,
five patients presented a deletion, two a duplication, two
had apparently balanced translocations, one had a 47,
XXY karyotype, three patients presented inversions and
one had a derivative chromosome. These cases were an-
alyzed by oligoarray-CGH to refine the breakpoints and
the genomic content of the rearrangements, or to deter-
mine if there were genomic imbalances involved in ap-
parently balanced translocations, as they can remain
undetected [18], and inversions carriers, or even to clar-
ify if there was an additional imbalance, like in the case
of a Klinefelter patient, which could explain a severe
phenotype.
DNA extraction
Genomic DNA was extracted from peripheral blood
lymphocytes using Jetquick blood and cell culture DNA
Midi Spin kit according to the manufacturers’ instruc-
tions (Genomed, Löhne, Germany). DNA concentration
and purity were measured using a NanoDrop1000 Spec-
trophotometer (Thermo Scientific, Waltham, USA).
Array-CGH
High-resolution whole genome analysis was performed
using Agilent SurePrint G3 Human Genome microar-
rays. Although 180 K oligonucleotide microarray format(Agilent Technologies, Santa Clara, CA, USA) was the
most used, the 60 K was requested for fifty-four cases.
These microarrays contain approximately 180 000 and
60 000 sixty-mer probes with a 17 kb and 54 kb average
probe spacing, respectively. Labeling was performed
using Agilent Genomic DNA enzymatic labeling kit
(Agilent Technologies, Santa Clara, CA, USA) and
clean-up of labeled genomic DNA was performed using
Amicon ultra 0.5 ml centrifugal filters according to man-
ufacturers’ instructions (Millipore, Billerica, MA, USA).
Slides were scanned on an Agilent scanner and proc-
essed with Feature Extraction software (v10.7). Each pa-
tient DNA was labeled both in Cy3 and Cy5 and
hybridized against the DNA of two phenotypically dis-
tinct patients according to the loop model [19]. Results
were analyzed using Agilent Genomic Workbench (v6.0
and v6.5) software with the following settings: ADM2 as
aberration algorithm, threshold of 6.0, moving average
2 Mb. The results are according to Human Genome
build 19 and include imbalances with at least three con-
secutive probes with abnormal log2 ratios. All the imbal-
ances were interpreted consulting the UCSC genome
browser (http://genome.ucsc.edu), Decipher (Database of
Chromosomal Imbalance and Phenotype in Humans
Using Ensembl Resources - http://decipher.sanger.ac.uk/),
ClinGen (Clinical Genome Resource - https://www.clini-
calgenome.org/), OMIM (Online Mendelian Inheritance
in Man - http://www.ncbi.nlm.nih.gov/omim) and DGV
(http://projects.tcag.ca) databases.Statistical analysis
The statistical analysis was mainly conducted aiming to
describe the proportions found in each group resorting
to suitable figures and tables. Association hypotheses re-
garding nominal variables were tested using the chi-
square test taking into account the Cochran rules for
validity of the test. The level of significance adopted was
0.05 %.
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